Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in United States (68Ga-FAP-2286, 177Lu-FAP-2286)

Recruiting
  • Solid Tumor
  • Birmingham, Alabama
  • +5 more
Aug 26, 2022

Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,

Recruiting
  • Solid Tumor
  • +7 more
  • BNT141
  • +2 more
  • Duarte, California
  • +10 more
Aug 23, 2022

Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

Completed
Has Results
  • Solid Tumor
  • +4 more
  • Mogamulizumab + Nivolumab
  • Gilbert, Arizona
  • +14 more
Jul 27, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

Active, not recruiting
  • Solid Tumor
  • +4 more
  • Nashville, Tennessee
  • +14 more
Jul 21, 2022

Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

Recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +10 more
Jul 20, 2022

Solid Tumor Trial in Singapore, Spain, United States (BNT142)

Recruiting
  • Solid Tumor
  • BNT142
  • Los Angeles, California
  • +9 more
Jul 21, 2022

Solid Tumor Trial in United States (CI-8993)

Recruiting
  • Solid Tumor
  • Lebanon, New Hampshire
  • +4 more
Jul 19, 2022

Oncology, Solid Tumor, Non Small Cell Lung Cancer Trial in United States (MRx0518, Pembrolizumab 25 MG/1 ML Intravenous Solution

Active, not recruiting
  • Oncology
  • +5 more
  • MRx0518
  • Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]
  • Kansas City, Kansas
  • +4 more
Jul 5, 2022

Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

Recruiting
  • Solid Tumor
  • +8 more
  • Los Angeles, California
  • +5 more
Jun 27, 2022

Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
Jun 14, 2022

Solid Tumor Trial in Houston (YL-13027)

Recruiting
  • Solid Tumor
  • Houston, Texas
    MD Anderson Cancer Center
May 16, 2022

Solid Tumor Trial in United States (KITE-718, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Solid Tumor
  • Gilbert, Arizona
  • +11 more
Apr 5, 2022

Solid Tumor Trial in Worldwide (Debio 1347)

Terminated
  • Solid Tumor
  • Debio 1347
  • Scottsdale, Arizona
  • +104 more
Mar 30, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Solid Tumor, Metastatic Cancer Trial in United States (TJ004309, Atezolizumab)

Active, not recruiting
  • Solid Tumor
  • Metastatic Cancer
  • Birmingham, Alabama
  • +3 more
Mar 31, 2022

Solid Tumor Trial in United States (ORIC-101, Nab-paclitaxel)

Active, not recruiting
  • Solid Tumor
  • Palo Alto, California
  • +11 more
Mar 22, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,

Recruiting
  • Solid Tumor
  • +8 more
  • TBio-6517
  • Pembrolizumab
  • Phoenix, Arizona
  • +10 more
Feb 21, 2022

Solid Tumor Trial in United States (PF-07284892, lorlatinib, binimetinib)

Recruiting
  • Solid Tumor
  • Orange, California
  • +6 more
Feb 15, 2022

Solid Tumor, Glioblastoma, NSCLC Trial in Nashville, Houston, Villejuif (TAS2940)

Recruiting
  • Solid Tumor
  • +3 more
  • Nashville, Tennessee
  • +2 more
Feb 25, 2022

Solid Tumor Trial in United States (Sirolimus, Cyclophosphamide, Etoposide)

Recruiting
  • Solid Tumor
  • Atlanta, Georgia
  • +4 more
Feb 8, 2022

Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

Recruiting
  • Bladder Cancer
  • +9 more
  • CAdVEC
  • Houston, Texas
    Baylor St. Luke's Medical Center
Feb 17, 2022